NO303526B1 - FremgangsmÕte for fremstilling av et farmas°ytisk preparat inneholdende probukol med forh°yet biotilgjengelighet - Google Patents

FremgangsmÕte for fremstilling av et farmas°ytisk preparat inneholdende probukol med forh°yet biotilgjengelighet

Info

Publication number
NO303526B1
NO303526B1 NO932236A NO932236A NO303526B1 NO 303526 B1 NO303526 B1 NO 303526B1 NO 932236 A NO932236 A NO 932236A NO 932236 A NO932236 A NO 932236A NO 303526 B1 NO303526 B1 NO 303526B1
Authority
NO
Norway
Prior art keywords
preparation
probucol
fatty acids
high bioavailability
pharmaceutical surface
Prior art date
Application number
NO932236A
Other languages
English (en)
Other versions
NO932236D0 (no
NO932236L (no
Inventor
Kenneth G Bassler
Deepak S Phadke
Melissa P Neddermeyer
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NO932236D0 publication Critical patent/NO932236D0/no
Publication of NO932236L publication Critical patent/NO932236L/no
Publication of NO303526B1 publication Critical patent/NO303526B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO932236A 1990-12-18 1993-06-17 FremgangsmÕte for fremstilling av et farmas°ytisk preparat inneholdende probukol med forh°yet biotilgjengelighet NO303526B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62954090A 1990-12-18 1990-12-18
PCT/US1991/008565 WO1992010996A1 (en) 1990-12-18 1991-11-15 Enhanced bioavailability pharmaceutical composition containing probucol

Publications (3)

Publication Number Publication Date
NO932236D0 NO932236D0 (no) 1993-06-17
NO932236L NO932236L (no) 1993-06-17
NO303526B1 true NO303526B1 (no) 1998-07-27

Family

ID=24523438

Family Applications (1)

Application Number Title Priority Date Filing Date
NO932236A NO303526B1 (no) 1990-12-18 1993-06-17 FremgangsmÕte for fremstilling av et farmas°ytisk preparat inneholdende probukol med forh°yet biotilgjengelighet

Country Status (17)

Country Link
EP (1) EP0563112B1 (no)
JP (1) JP3127998B2 (no)
KR (1) KR0177845B1 (no)
AT (1) ATE117200T1 (no)
AU (1) AU647563B2 (no)
CA (1) CA2097827C (no)
DE (1) DE69106892T2 (no)
DK (1) DK0563112T3 (no)
ES (1) ES2069987T3 (no)
FI (1) FI102457B1 (no)
GR (1) GR3015837T3 (no)
HU (1) HU210565B (no)
IE (1) IE65578B1 (no)
IL (1) IL100390A (no)
NO (1) NO303526B1 (no)
NZ (1) NZ240961A (no)
WO (1) WO1992010996A1 (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995031979A1 (en) * 1994-05-19 1995-11-30 R.P. Scherer International Corporation Solutions of aryl or heteroaryl substituted alkanoic acids in lipophilic solvents and soft gelatin capsules containing such solutions
US5858401A (en) * 1996-01-22 1999-01-12 Sidmak Laboratories, Inc. Pharmaceutical composition for cyclosporines
US6814977B1 (en) 1998-12-18 2004-11-09 Abbott Laboratories Formulations comprising lipid-regulating agents
US7014864B1 (en) 1998-12-18 2006-03-21 Abbott Laboratories Formulations comprising lipid-regulating agents
CA2355820A1 (en) * 1998-12-18 2000-06-29 Abbott Laboratories Novel formulations comprising lipid-regulating agents
US6838091B2 (en) 1998-12-18 2005-01-04 Abbott Laboratories Formulations comprising lipid-regulating agents
EP1172104A4 (en) * 1999-02-23 2002-11-27 Chugai Pharmaceutical Co Ltd PREPARATIONS FROM SOFT POCKET CAPSULES CONTAINING DIHYDROBENZOFURANE DERIVATIVES
US6719999B2 (en) 1999-03-31 2004-04-13 Abbott Laboratories Formulations comprising lipid-regulating agents
US6372251B2 (en) 1999-06-11 2002-04-16 Abbott Laboratories Formulations comprising lipid-regulating agents
WO2005037251A1 (en) * 2003-10-17 2005-04-28 Amylin Pharmaceuticals, Inc. Self-emulsifying drug delivery systems for hydrophobic therapeutic compounds
WO2024006748A1 (en) * 2022-07-01 2024-01-04 Acrotech Biopharma Inc. Pharmaceutical compositions comprising isotretinoin and processes for preparation and uses thereof
CN116617179B (zh) * 2023-05-19 2024-03-29 齐鲁制药有限公司 一种普罗布考软胶囊及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3862332A (en) * 1967-05-11 1975-01-21 Dow Chemical Co Method of lowering serum cholesterol
US4902513A (en) * 1987-07-31 1990-02-20 Jean Carvais Oral sustained release medicament

Also Published As

Publication number Publication date
EP0563112A1 (en) 1993-10-06
AU647563B2 (en) 1994-03-24
ES2069987T3 (es) 1995-05-16
AU9067891A (en) 1992-07-22
NZ240961A (en) 1994-03-25
JP3127998B2 (ja) 2001-01-29
HU210565B (en) 1995-05-29
DE69106892T2 (de) 1995-05-18
DE69106892D1 (de) 1995-03-02
FI932769A0 (fi) 1993-06-16
FI932769A (fi) 1993-06-16
KR930702965A (ko) 1993-11-29
FI102457B (fi) 1998-12-15
ATE117200T1 (de) 1995-02-15
CA2097827C (en) 2002-07-23
IL100390A (en) 1996-12-05
GR3015837T3 (en) 1995-07-31
EP0563112B1 (en) 1995-01-18
DK0563112T3 (da) 1995-04-10
NO932236D0 (no) 1993-06-17
IE914401A1 (en) 1992-07-01
IL100390A0 (en) 1992-09-06
WO1992010996A1 (en) 1992-07-09
KR0177845B1 (ko) 1999-03-20
CA2097827A1 (en) 1992-06-19
FI102457B1 (fi) 1998-12-15
NO932236L (no) 1993-06-17
HU9301769D0 (en) 1993-09-28
IE65578B1 (en) 1995-11-01
JPH06503340A (ja) 1994-04-14
HUT64218A (en) 1993-12-28

Similar Documents

Publication Publication Date Title
ATE153854T1 (de) Stabile pharmazeutische zubereitung mit fumagillolderivaten
ATE15443T1 (de) Essbare, pharmazeutische zusammensetzungen und verfahren zur herstellung.
PT93884A (pt) Processo de preparacao de uma composicao farmaceutica a base de acido 5-amino-salicilico, sob a forma de uma espuma
NO303526B1 (no) FremgangsmÕte for fremstilling av et farmas°ytisk preparat inneholdende probukol med forh°yet biotilgjengelighet
NO176082C (no) Fremgangsmåte for fremstilling av et farmasöytisk preparat inneholdende bunazosin, for perkutan tilförsel
FI904395A0 (fi) 4-hydroxitetrahydropyran-2-oner samt motsvarande dihydroxikarboxylsyra derivat, salter och estrar, foerfarande foer deras framstaellning, deras anvaendning saosom laekemedel, farmaceutiska produkter samt foerprodukter.
HUT52374A (en) Process for producing pharmaceutical compositions
FR2702660B1 (fr) Compositions thérapeutiques stabilisées et leur procédé de préparation.
NO175307C (no) Analogifremgangsmåte for fremstilling av nye terapeutisk aktive 3,3'-ditiobis(propionsyrer)
BE1002024A6 (fr) Preparation medicamenteuse a base de derives d'esters d'hecogenine et leur utilisation pour le traitement de l'hyperplasie prostatique benigne.
HUT61024A (en) Process for producing 10(1-hydroxyethyl)-11-oxo-1-aza-tricyclo/7.2.0.0.3.8/undex-2-ene-2-carboxylic acid esters and pharmaceutical compositions comprising same as active ingredient
FR2692263B1 (fr) Procédé de préparation d'esters cycliques d'acides-alpha-hydroxycarboxyliques.
FI942581A (fi) Menetelmä 5-bromi-6-metoksi-1-naftoehappometyyliesterin valmistamiseksi
IT1204571B (it) Esteri di 1,4:3,6-dianidrosorbitolo-2-mononitrato e 5-mononitrato,loro procedimento di preparazione e loro composizioni farmaceutiche
SE8104657L (sv) Injicerbara farmaceutiska kompositioner
ES2062507T3 (es) Acido flavonacetico fluorado.
IT8019878A0 (it) Esteri di acidi arilpropilonici adattivita' antiinfiammatoria, processo per la loro preparazione, e composizioni farmaceutiche relative.
IT8620737A1 (it) Composizioni farmaceutiche contenenti levodopa metil estere, loro procedimento di preparazione e relative applicazioni terapeutiche
IT9019485A0 (it) Acidi 2-(2,4-diaril-ossazol-5-il)-alcancarbossilici,loro esteri e salimetodi per la loro preparazione e composizioni farmaceutiche che li contengono
ITMI911206A0 (it) Formulazioni farmaceutiche per il trattamento di malattie periferiche vascolari
IT7945204A0 (it) Composizione farmaceutica per la terapia delle sterilita' maschile
NO943458D0 (no) Fremgangsmåte for fremstilling av terapeutisk aktivt amphiregulin
IT7827747A0 (it) Processo per la preparazione di esteri non simmetrici di acidi 1,4-diidropiridin-dicarbossilici eloro impiego come farmaci.

Legal Events

Date Code Title Description
MK1K Patent expired